Interface has secured $3 million in an oversubscribed seed funding round to advance its AI drug discovery platform for inflammatory disease→

Interface Bio emerges with $3m to harness the microbiome against inflammation. The AI-powered platform identifies bacterial natural products with the potential to modulate the immune system and reduce inflammation.

Read More —>